Biotech Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B July 3, 2026
Biotech Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC July 2, 2026
Biotech Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase) June 28, 2026
Biotech Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis June 27, 2026
Biotech Pendulum Therapeutics Appoints Madison Reed Founder and CEO Amy Errett to Board of Directors June 26, 2026
Biotech Rare Neurological Disease Treatment Market to Reach USD 43.7 Billion by 2036 as Orphan Drug Approvals and Genetic Diagnostics Expand Specialist Care | Future Market Insights June 25, 2026
Search
Biotech
July 4, 2026
July 3, 2026
July 2, 2026
July 1, 2026
June 30, 2026
June 29, 2026
June 28, 2026
June 27, 2026
June 26, 2026
June 25, 2026
